SOHM, Inc. SHMN
Set alert
At close · Oct 30
- YTD
- -25.56%
- 1 year
- -44.17%
- Open
- 0.0008
- Prev close
- 0.0006
- Mkt cap
- 1.94M
- Vol
- 1.13M
- Avg vol
- 910.45K
- EPS
- -0.002
- P/E
- 0.00
More statistics
- Low
- 0.0007
- High
- 0.0008
News
12 months ago accessnewswire.com
SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in…
12 months ago accessnewswire.com
SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in…
1 year ago accessnewswire.com
SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
CHINO HILLS, CA / ACCESS Newswire / September 2, 2025 / SOHM, Inc. (OTCID:SHMN), a leading pharmaceutical company developing next-generation gene editing solutions, today announced the relocation of…
1 year ago accessnewswire.com
SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities
Advanced dCas12a Technology Successfully Modifies Human Cells, Positioning Company for Multi-Target Editing Capabilities CHINO HILLS, CALIFORNIA / ACCESS Newswire / August 26, 2025 / SOHM, Inc. (OTC…
1 year ago accessnewswire.com
SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
CHINO HILLS, CALIFORNIA / ACCESS Newswire / July 21, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading innovator in pharmaceuticals, nutraceuticals, topicals, and biotechnology, is excited to announce the…
1 year ago accessnewswire.com
SOHM, Inc. Appoints Ravi Kapoor as an Independent Director
CHINO HILLS, CA / ACCESS Newswire / June 30, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and…
1 year ago accessnewswire.com
SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
CHINO HILLS, CALIFORNIA / ACCESS Newswire / June 24, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health…
1 year ago accessnewswire.com
SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
CHINO HILLS, CA / ACCESS Newswire / June 11, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and…
1 year ago accessnewswire.com
SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development
CHINO HILLS, CA / ACCESS Newswire / June 4, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and…
1 year ago accessnewswire.com
SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 / SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development…
1 year ago accessnewswire.com
Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization
CHINO HILLS, CA / ACCESS Newswire / May 2, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly…
1 year ago accessnewswire.com
SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology
CHINO HILLS, CA / ACCESS Newswire / May 1, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly…
1 year ago accessnewswire.com
SOHM, Inc. Announces Patent Allowance/Approval in South Korea
CHINO HILLS, CA / ACCESS Newswire / April 16, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene…
1 year ago accessnewswire.com
SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE
CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to…
1 year ago accessnewswire.com
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce…
1 year ago accessnewswire.com
SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology
CHINO HILLS, CA / ACCESS Newswire / March 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, has announced today…
1 year ago accesswire.com
SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant
CHINO HILLS, CA / ACCESSWIRE / November 20, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has…
1 year ago accesswire.com
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes
For Pharmaceutical, Nutraceutical, Cosmeceutical & Strategic Partnered Products CHINO HILLS, CA / ACCESSWIRE / November 14, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology…
2 years ago accesswire.com
SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space
CHINO HILLS, CA / ACCESSWIRE / October 2, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has filed…
2 years ago accesswire.com
SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders
CHINO HILLS, CA / ACCESSWIRE / September 25, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has…